Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes

BACKGROUND: Treatment decisions for older patients with type 2 diabetes mellitus must balance glycemic control and adverse event risk. The objective of this study was to evaluate the long-term safety and tolerability of saxagliptin 5 mg as add-on therapy to common antihyperglycemic drugs in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Nayyar, Allen, Elsie, Öhman, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158996/
https://www.ncbi.nlm.nih.gov/pubmed/25214775
http://dx.doi.org/10.2147/CIA.S68193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158996/
https://www.ncbi.nlm.nih.gov/pubmed/25214775
http://dx.doi.org/10.2147/CIA.S68193

Ejemplares similares